Literature DB >> 3668738

Polycystic kidney disease in the first year of life.

B R Cole1, S B Conley, F B Stapleton.   

Abstract

To determine the frequency of autosomal recessive and autosomal dominant polycystic kidney disease (PKD) in infants and to compare the rate of progression of these conditions, we conducted a retrospective survey of 48 patients who were seen with PKD before 1 year of age and who survived the first month of age. Seventeen patients had recessive PKD; six had dominant PKD. Eighteen patients had insufficient data to categorize the type of PKD with certainty. Seven patients were classified as "other"; three had glomerulocystic disease and the remainder had multiple malformation syndromes or tuberous sclerosis. Renal ultrasonography and excretory urography accurately detected 15 of 17 patients with recessive PKD, but only one patient with dominant PKD was correctly diagnosed by excretory urography. The majority of patients in all groups required antihypertensive therapy. The 17 children with recessive PKD have been followed up for 6.1 +/- 4.3 (SD) years. Eight patients are doing well. Two patients have died; five others have required treatment for renal failure. Only one patient has an estimated glomerular filtration rate within the normal range after 6 years of age. Long-term evaluation of most of the patients with dominant PKD is not yet available; however, by age 42 months one patient has required dialysis. To provide optimum genetic counseling and accurate diagnosis for patients with PKD, a combination of careful family evaluation, radiography, and liver or kidney biopsy is required. The outcome of patients who survive the neonatal period appears not to be so grim as previously feared, underscoring the importance of aggressive supportive care and the need for physician and family education.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668738     DOI: 10.1016/s0022-3476(87)80244-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  Role of genetic modifiers in an orthologous rat model of ARPKD.

Authors:  Caitlin C O'Meara; Matthew Hoffman; William E Sweeney; Shirng-Wern Tsaih; Bing Xiao; Howard J Jacob; Ellis D Avner; Carol Moreno
Journal:  Physiol Genomics       Date:  2012-06-05       Impact factor: 3.107

2.  Autosomal recessive polycystic kidney disease: improvement of renal function.

Authors:  Bettina M Bosch; Christian Plank; Wolfgang Rascher; Jörg Dötsch
Journal:  Eur J Pediatr       Date:  2003-03-22       Impact factor: 3.183

Review 3.  Trials and tribulations of multicenter studies. Lessons learned from the experiences of the Southwest Pediatric Nephrology Study Group (SPNSG).

Authors:  R J Hogg
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

Review 4.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

5.  Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.

Authors:  Marusia Lilova; Bernard S Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2002-11-26       Impact factor: 3.714

6.  Does liver biopsy provide sufficient diagnostic information to differentiate autosomal recessive from autosomal dominant polycystic kidney disease?

Authors:  B R Cole
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

7.  Renal cystic disease of infancy: results of histochemical studies. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  R Verani; P Walker; F G Silva
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

8.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

9.  Glomerulocystic disease: unilateral involvement of a horseshoe kidney and in trisomy 18.

Authors:  R D Craver; J Ortenberg; R Baliga
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

10.  IFT80 is essential for chondrocyte differentiation by regulating Hedgehog and Wnt signaling pathways.

Authors:  Changdong Wang; Xue Yuan; Shuying Yang
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.